Kexing Biopharm (688136.SH): Marketing authorization application for pegylated human granulocyte colony-stimulating factor injection accepted
Kexing Biopharm (688136.SH) announced that recently, the company received the "Notice of Acceptance" issued by the National Medical Products Administration regarding the marketing authorization application for its investigational drug pegylated human granulocyte colony-stimulating factor injection (referred to as "GB-K02"). The company's GB-K02 is indicated for reducing the incidence of infection, manifested as febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anticancer drugs that are prone to cause clinically significant febrile neutropenia.
Kexing Biopharm (688136.SH) announced that recently, the company received the "Notice of Acceptance" issued by the National Medical Products Administration for the marketing authorization application of its investigational drug pegylated human granulocyte colony-stimulating factor injection (referred to as "GB-K02"). The company's GB-K02 is indicated for reducing the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
Related Articles
Zhejiang EV-Tech (301607.SZ)'s major shareholder Changjiang NIO Industry Fund plans to reduce its stake by no more than 2.894%.
Nanjing Sciyon Wisdom Technology Group (002380.SZ): Plans to transfer 70% equity and creditor's rights of Lingbi Guozhen, a controlled subsidiary, for 35 million yuan.
Biwin Storage Technology (688525.SH): As of September 30, a total of 1,044,700 shares were repurchased at a cost of 222 million yuan.
Zhejiang EV-Tech (301607.SZ)'s major shareholder Changjiang NIO Industry Fund plans to reduce its stake by no more than 2.894%.
Nanjing Sciyon Wisdom Technology Group (002380.SZ): Plans to transfer 70% equity and creditor's rights of Lingbi Guozhen, a controlled subsidiary, for 35 million yuan.
Biwin Storage Technology (688525.SH): As of September 30, a total of 1,044,700 shares were repurchased at a cost of 222 million yuan.
